nodes	percent_of_prediction	percent_of_DWPC	metapath
Arsenic trioxide—ABCC2—Cyclosporine—focal segmental glomerulosclerosis	0.239	0.657	CbGbCtD
Arsenic trioxide—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.078	0.214	CbGbCtD
Arsenic trioxide—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0467	0.128	CbGbCtD
Arsenic trioxide—MAPK3—nephron—focal segmental glomerulosclerosis	0.0286	0.118	CbGeAlD
Arsenic trioxide—AKT1—nephron—focal segmental glomerulosclerosis	0.027	0.112	CbGeAlD
Arsenic trioxide—JUN—nephron—focal segmental glomerulosclerosis	0.0235	0.0972	CbGeAlD
Arsenic trioxide—MAPK3—endothelium—focal segmental glomerulosclerosis	0.0135	0.0558	CbGeAlD
Arsenic trioxide—AKT1—endothelium—focal segmental glomerulosclerosis	0.0127	0.0526	CbGeAlD
Arsenic trioxide—JUN—endothelium—focal segmental glomerulosclerosis	0.0111	0.0458	CbGeAlD
Arsenic trioxide—CCND1—nephron tubule—focal segmental glomerulosclerosis	0.00828	0.0343	CbGeAlD
Arsenic trioxide—CCND1—kidney—focal segmental glomerulosclerosis	0.00728	0.0301	CbGeAlD
Arsenic trioxide—CCND1—cortex of kidney—focal segmental glomerulosclerosis	0.00709	0.0293	CbGeAlD
Arsenic trioxide—MAPK1—nephron tubule—focal segmental glomerulosclerosis	0.00698	0.0289	CbGeAlD
Arsenic trioxide—TXNRD1—nephron tubule—focal segmental glomerulosclerosis	0.0065	0.0269	CbGeAlD
Arsenic trioxide—MAPK3—nephron tubule—focal segmental glomerulosclerosis	0.00618	0.0256	CbGeAlD
Arsenic trioxide—MAPK1—kidney—focal segmental glomerulosclerosis	0.00613	0.0254	CbGeAlD
Arsenic trioxide—MAPK1—cortex of kidney—focal segmental glomerulosclerosis	0.00597	0.0247	CbGeAlD
Arsenic trioxide—TXNRD1—kidney—focal segmental glomerulosclerosis	0.00571	0.0236	CbGeAlD
Arsenic trioxide—TXNRD1—cortex of kidney—focal segmental glomerulosclerosis	0.00556	0.023	CbGeAlD
Arsenic trioxide—MAPK3—kidney—focal segmental glomerulosclerosis	0.00543	0.0225	CbGeAlD
Arsenic trioxide—MAPK3—cortex of kidney—focal segmental glomerulosclerosis	0.00529	0.0219	CbGeAlD
Arsenic trioxide—AKT1—kidney—focal segmental glomerulosclerosis	0.00512	0.0212	CbGeAlD
Arsenic trioxide—JUN—nephron tubule—focal segmental glomerulosclerosis	0.00507	0.021	CbGeAlD
Arsenic trioxide—AKT1—cortex of kidney—focal segmental glomerulosclerosis	0.00499	0.0206	CbGeAlD
Arsenic trioxide—JUN—kidney—focal segmental glomerulosclerosis	0.00446	0.0184	CbGeAlD
Arsenic trioxide—JUN—cortex of kidney—focal segmental glomerulosclerosis	0.00434	0.018	CbGeAlD
Arsenic trioxide—IKBKB—cortex of kidney—focal segmental glomerulosclerosis	0.00432	0.0179	CbGeAlD
Arsenic trioxide—ABCC2—nephron tubule—focal segmental glomerulosclerosis	0.00276	0.0114	CbGeAlD
Arsenic trioxide—CYP1B1—nephron tubule—focal segmental glomerulosclerosis	0.0027	0.0112	CbGeAlD
Arsenic trioxide—ABCC2—kidney—focal segmental glomerulosclerosis	0.00243	0.01	CbGeAlD
Arsenic trioxide—CYP1B1—kidney—focal segmental glomerulosclerosis	0.00238	0.00983	CbGeAlD
Arsenic trioxide—ABCC2—cortex of kidney—focal segmental glomerulosclerosis	0.00236	0.00977	CbGeAlD
Arsenic trioxide—CYP1B1—cortex of kidney—focal segmental glomerulosclerosis	0.00231	0.00957	CbGeAlD
Arsenic trioxide—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00168	0.00695	CbGeAlD
Arsenic trioxide—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00123	0.0051	CbGeAlD
Arsenic trioxide—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000993	0.00411	CbGeAlD
Arsenic trioxide—ABCB1—kidney—focal segmental glomerulosclerosis	0.000872	0.00361	CbGeAlD
Arsenic trioxide—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.00085	0.00351	CbGeAlD
Arsenic trioxide—MAPK1—Spinal Cord Injury—TGFB1—focal segmental glomerulosclerosis	0.000122	0.000309	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.000122	0.000309	CbGpPWpGaD
Arsenic trioxide—AKT1—TGF-beta Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000121	0.000306	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	0.000119	0.000302	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—LPL—focal segmental glomerulosclerosis	0.000117	0.000298	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.000117	0.000297	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.000117	0.000296	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000117	0.000296	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000116	0.000294	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—MYH9—focal segmental glomerulosclerosis	0.000112	0.000284	CbGpPWpGaD
Arsenic trioxide—MAPK1—TGF-beta Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000111	0.000283	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	0.000108	0.000275	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—MYH9—focal segmental glomerulosclerosis	0.000107	0.000272	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	0.000107	0.000272	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—MYH9—focal segmental glomerulosclerosis	0.000104	0.000264	CbGpPWpGaD
Arsenic trioxide—JUN—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	0.000104	0.000263	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—LPL—focal segmental glomerulosclerosis	0.000101	0.000257	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—AGT—focal segmental glomerulosclerosis	0.0001	0.000255	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	9.98e-05	0.000253	CbGpPWpGaD
Arsenic trioxide—AKT1—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	9.96e-05	0.000253	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—AGT—focal segmental glomerulosclerosis	9.94e-05	0.000252	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	9.92e-05	0.000252	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—MYH9—focal segmental glomerulosclerosis	9.91e-05	0.000251	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—LPL—focal segmental glomerulosclerosis	9.82e-05	0.000249	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.76e-05	0.000248	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	9.74e-05	0.000247	CbGpPWpGaD
Arsenic trioxide—ABCC2—NRF2 pathway—TGFB1—focal segmental glomerulosclerosis	9.69e-05	0.000246	CbGpPWpGaD
Arsenic trioxide—MAPK3—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	9.66e-05	0.000245	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—MYH9—focal segmental glomerulosclerosis	9.48e-05	0.000241	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD79A—focal segmental glomerulosclerosis	9.47e-05	0.00024	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	9.45e-05	0.00024	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.37e-05	0.000238	CbGpPWpGaD
Arsenic trioxide—JUN—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	9.36e-05	0.000237	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—LPL—focal segmental glomerulosclerosis	9.34e-05	0.000237	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—MMP2—focal segmental glomerulosclerosis	9.22e-05	0.000234	CbGpPWpGaD
Arsenic trioxide—MAPK1—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	9.19e-05	0.000233	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	9.09e-05	0.000231	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	9.06e-05	0.00023	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	9.01e-05	0.000229	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle, Mitotic—PCNA—focal segmental glomerulosclerosis	8.99e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—AKT1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.99e-05	0.000228	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.97e-05	0.000227	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	8.91e-05	0.000226	CbGpPWpGaD
Arsenic trioxide—IKBKB—MAPK Signaling Pathway—TGFB1—focal segmental glomerulosclerosis	8.79e-05	0.000223	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	8.79e-05	0.000223	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—MMP2—focal segmental glomerulosclerosis	8.77e-05	0.000223	CbGpPWpGaD
Arsenic trioxide—AKT1—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	8.74e-05	0.000222	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	8.74e-05	0.000222	CbGpPWpGaD
Arsenic trioxide—MAPK3—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.72e-05	0.000221	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	8.65e-05	0.000219	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.61e-05	0.000219	CbGpPWpGaD
Arsenic trioxide—MAPK3—Cell Cycle—PCNA—focal segmental glomerulosclerosis	8.45e-05	0.000214	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	8.36e-05	0.000212	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	8.35e-05	0.000212	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	8.34e-05	0.000212	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	8.31e-05	0.000211	CbGpPWpGaD
Arsenic trioxide—MAPK1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	8.3e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	8.28e-05	0.00021	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—focal segmental glomerulosclerosis	8.23e-05	0.000209	CbGpPWpGaD
Arsenic trioxide—MAPK1—Cell Cycle—PCNA—focal segmental glomerulosclerosis	8.04e-05	0.000204	CbGpPWpGaD
Arsenic trioxide—AKT1—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	8e-05	0.000203	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	7.95e-05	0.000202	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—FN1—focal segmental glomerulosclerosis	7.85e-05	0.000199	CbGpPWpGaD
Arsenic trioxide—MAPK3—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	7.76e-05	0.000197	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—NOS2—focal segmental glomerulosclerosis	7.76e-05	0.000197	CbGpPWpGaD
Arsenic trioxide—IKBKB—Adaptive Immune System—CD40LG—focal segmental glomerulosclerosis	7.72e-05	0.000196	CbGpPWpGaD
Arsenic trioxide—TXNRD1—Metabolism—ALB—focal segmental glomerulosclerosis	7.71e-05	0.000196	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	7.63e-05	0.000194	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—FN1—focal segmental glomerulosclerosis	7.61e-05	0.000193	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	7.61e-05	0.000193	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—focal segmental glomerulosclerosis	7.58e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.58e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	7.57e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	7.56e-05	0.000192	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—NOS2—focal segmental glomerulosclerosis	7.52e-05	0.000191	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	7.51e-05	0.000191	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—CTGF—focal segmental glomerulosclerosis	7.47e-05	0.00019	CbGpPWpGaD
Arsenic trioxide—ABCB1—Allograft Rejection—TGFB1—focal segmental glomerulosclerosis	7.45e-05	0.000189	CbGpPWpGaD
Arsenic trioxide—MAPK1—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	7.38e-05	0.000187	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	7.35e-05	0.000186	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	7.33e-05	0.000186	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.28e-05	0.000185	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—CTGF—focal segmental glomerulosclerosis	7.24e-05	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—FN1—focal segmental glomerulosclerosis	7.24e-05	0.000184	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—NOS2—focal segmental glomerulosclerosis	7.16e-05	0.000182	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	7.06e-05	0.000179	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	6.99e-05	0.000177	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	6.94e-05	0.000176	CbGpPWpGaD
Arsenic trioxide—MAPK3—Axon guidance—MMP9—focal segmental glomerulosclerosis	6.93e-05	0.000176	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.93e-05	0.000176	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—MMP2—focal segmental glomerulosclerosis	6.78e-05	0.000172	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD79A—focal segmental glomerulosclerosis	6.77e-05	0.000172	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.72e-05	0.00017	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.72e-05	0.00017	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—CTGF—focal segmental glomerulosclerosis	6.68e-05	0.000169	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—LIPC—focal segmental glomerulosclerosis	6.6e-05	0.000167	CbGpPWpGaD
Arsenic trioxide—MAPK1—Axon guidance—MMP9—focal segmental glomerulosclerosis	6.59e-05	0.000167	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—MMP2—focal segmental glomerulosclerosis	6.58e-05	0.000167	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	6.53e-05	0.000166	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—ALB—focal segmental glomerulosclerosis	6.52e-05	0.000165	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD79A—focal segmental glomerulosclerosis	6.51e-05	0.000165	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	6.47e-05	0.000164	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	6.43e-05	0.000163	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	6.43e-05	0.000163	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	6.39e-05	0.000162	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	6.33e-05	0.000161	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—ALB—focal segmental glomerulosclerosis	6.32e-05	0.00016	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD79A—focal segmental glomerulosclerosis	6.31e-05	0.00016	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	6.27e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—MMP2—focal segmental glomerulosclerosis	6.26e-05	0.000159	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	6.03e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—ALB—focal segmental glomerulosclerosis	6.02e-05	0.000153	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD79A—focal segmental glomerulosclerosis	6e-05	0.000152	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.87e-05	0.000149	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—CTGF—focal segmental glomerulosclerosis	5.81e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	5.79e-05	0.000147	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD79A—focal segmental glomerulosclerosis	5.74e-05	0.000146	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.7e-05	0.000145	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—TRPC6—focal segmental glomerulosclerosis	5.59e-05	0.000142	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.57e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.54e-05	0.000141	CbGpPWpGaD
Arsenic trioxide—JUN—Immune System—CD40LG—focal segmental glomerulosclerosis	5.52e-05	0.00014	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—LIPC—focal segmental glomerulosclerosis	5.48e-05	0.000139	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	5.42e-05	0.000138	CbGpPWpGaD
Arsenic trioxide—AKT1—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	5.37e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.35e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—GNAQ—focal segmental glomerulosclerosis	5.35e-05	0.000136	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.32e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—AKT1—Immune System—CD40LG—focal segmental glomerulosclerosis	5.3e-05	0.000135	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	5.19e-05	0.000132	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	5.16e-05	0.000131	CbGpPWpGaD
Arsenic trioxide—MAPK3—Immune System—CD40LG—focal segmental glomerulosclerosis	5.14e-05	0.000131	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—MMP9—focal segmental glomerulosclerosis	5.1e-05	0.000129	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—MMP9—focal segmental glomerulosclerosis	4.95e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.94e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	4.93e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.91e-05	0.000125	CbGpPWpGaD
Arsenic trioxide—ABCC2—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	4.91e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—MAPK1—Immune System—CD40LG—focal segmental glomerulosclerosis	4.89e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.87e-05	0.000124	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—CTGF—focal segmental glomerulosclerosis	4.83e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	4.82e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—LPL—focal segmental glomerulosclerosis	4.81e-05	0.000122	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.73e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	4.73e-05	0.00012	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—MMP9—focal segmental glomerulosclerosis	4.71e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	4.7e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—IKBKB—Immune System—CD40LG—focal segmental glomerulosclerosis	4.68e-05	0.000119	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—LPL—focal segmental glomerulosclerosis	4.66e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.66e-05	0.000118	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—LPL—focal segmental glomerulosclerosis	4.63e-05	0.000117	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	4.5e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.47e-05	0.000114	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—GNAQ—focal segmental glomerulosclerosis	4.45e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—LPL—focal segmental glomerulosclerosis	4.44e-05	0.000113	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.34e-05	0.00011	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.26e-05	0.000108	CbGpPWpGaD
Arsenic trioxide—AKT1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.2e-05	0.000107	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	4.13e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—AKT1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4.12e-05	0.000105	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	4.09e-05	0.000104	CbGpPWpGaD
Arsenic trioxide—MAPK3—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	4.08e-05	0.000103	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—LPL—focal segmental glomerulosclerosis	4.03e-05	0.000102	CbGpPWpGaD
Arsenic trioxide—MAPK3—Hemostasis—TGFB1—focal segmental glomerulosclerosis	4e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.97e-05	0.000101	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—AGT—focal segmental glomerulosclerosis	3.96e-05	0.0001	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	3.95e-05	0.0001	CbGpPWpGaD
Arsenic trioxide—MAPK1—Developmental Biology—TGFB1—focal segmental glomerulosclerosis	3.88e-05	9.84e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Hemostasis—TGFB1—focal segmental glomerulosclerosis	3.8e-05	9.65e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.78e-05	9.58e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—NOS2—focal segmental glomerulosclerosis	3.75e-05	9.53e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	3.69e-05	9.37e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—focal segmental glomerulosclerosis	3.68e-05	9.33e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—NOS2—focal segmental glomerulosclerosis	3.64e-05	9.24e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	3.61e-05	9.17e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.61e-05	9.16e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.5e-05	8.89e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.47e-05	8.8e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—NOS2—focal segmental glomerulosclerosis	3.46e-05	8.79e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—AGT—focal segmental glomerulosclerosis	3.44e-05	8.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	3.41e-05	8.64e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—LIPC—focal segmental glomerulosclerosis	3.38e-05	8.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.37e-05	8.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.36e-05	8.54e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—LPL—focal segmental glomerulosclerosis	3.35e-05	8.49e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.32e-05	8.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Gene Expression—SERPINE1—focal segmental glomerulosclerosis	3.3e-05	8.38e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.26e-05	8.28e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.2e-05	8.12e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.19e-05	8.09e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—SERPINE1—focal segmental glomerulosclerosis	3.16e-05	8.02e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—LPL—focal segmental glomerulosclerosis	3.11e-05	7.88e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	3.09e-05	7.85e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—SERPINE1—focal segmental glomerulosclerosis	3.07e-05	7.78e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	3.06e-05	7.77e-05	CbGpPWpGaD
Arsenic trioxide—CCND1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	3.04e-05	7.72e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism of lipids and lipoproteins—ALB—focal segmental glomerulosclerosis	3.04e-05	7.71e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—AGT—focal segmental glomerulosclerosis	3e-05	7.6e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.97e-05	7.54e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—LPL—focal segmental glomerulosclerosis	2.97e-05	7.54e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.94e-05	7.47e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—SERPINE1—focal segmental glomerulosclerosis	2.92e-05	7.4e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.88e-05	7.31e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—AGT—focal segmental glomerulosclerosis	2.86e-05	7.26e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	2.81e-05	7.14e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.79e-05	7.09e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.77e-05	7.03e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.74e-05	6.95e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LIPC—focal segmental glomerulosclerosis	2.7e-05	6.84e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.66e-05	6.75e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.66e-05	6.74e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Metabolism—ALB—focal segmental glomerulosclerosis	2.64e-05	6.71e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.58e-05	6.55e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—AGT—focal segmental glomerulosclerosis	2.54e-05	6.45e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.46e-05	6.23e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—CTGF—focal segmental glomerulosclerosis	2.37e-05	6.03e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—FN1—focal segmental glomerulosclerosis	2.35e-05	5.96e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Transmembrane transport of small molecules—ALB—focal segmental glomerulosclerosis	2.31e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.3e-05	5.85e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.21e-05	5.62e-05	CbGpPWpGaD
Arsenic trioxide—CYP1B1—Metabolism—ALB—focal segmental glomerulosclerosis	2.2e-05	5.57e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—GNAQ—focal segmental glomerulosclerosis	2.19e-05	5.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.15e-05	5.45e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—LPL—focal segmental glomerulosclerosis	2.06e-05	5.23e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	2.04e-05	5.18e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Disease—TGFB1—focal segmental glomerulosclerosis	2e-05	5.06e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	1.95e-05	4.96e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Disease—TGFB1—focal segmental glomerulosclerosis	1.94e-05	4.91e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Disease—TGFB1—focal segmental glomerulosclerosis	1.84e-05	4.67e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.77e-05	4.48e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—AGT—focal segmental glomerulosclerosis	1.76e-05	4.47e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.7e-05	4.3e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LIPC—focal segmental glomerulosclerosis	1.66e-05	4.22e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—LPL—focal segmental glomerulosclerosis	1.65e-05	4.18e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.64e-05	4.17e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.57e-05	3.97e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	1.5e-05	3.8e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—CTGF—focal segmental glomerulosclerosis	1.46e-05	3.71e-05	CbGpPWpGaD
Arsenic trioxide—JUN—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.45e-05	3.69e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—AGT—focal segmental glomerulosclerosis	1.41e-05	3.57e-05	CbGpPWpGaD
Arsenic trioxide—AKT1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.4e-05	3.55e-05	CbGpPWpGaD
Arsenic trioxide—MAPK3—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.36e-05	3.44e-05	CbGpPWpGaD
Arsenic trioxide—CYP1A1—Metabolism—ALB—focal segmental glomerulosclerosis	1.35e-05	3.43e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—GNAQ—focal segmental glomerulosclerosis	1.35e-05	3.42e-05	CbGpPWpGaD
Arsenic trioxide—MAPK1—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.29e-05	3.27e-05	CbGpPWpGaD
Arsenic trioxide—IKBKB—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	1.23e-05	3.13e-05	CbGpPWpGaD
Arsenic trioxide—ABCB1—Metabolism—ALB—focal segmental glomerulosclerosis	1.08e-05	2.74e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—LPL—focal segmental glomerulosclerosis	1.01e-05	2.57e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—AGT—focal segmental glomerulosclerosis	8.68e-06	2.2e-05	CbGpPWpGaD
Arsenic trioxide—CYP3A4—Metabolism—ALB—focal segmental glomerulosclerosis	6.66e-06	1.69e-05	CbGpPWpGaD
